Lengyel E - Search Results

1

Ovarian cancer development and metastasis.

Lengyel E. Lengyel E. Am J Pathol. 2010 Sep;177(3):1053-64. doi: 10.2353/ajpath.2010.100105. Epub 2010 Jul 22. Am J Pathol. 2010. PMID: 20651229 Free PMC article.

2

Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.

Schmalfeldt B, Prechtel D, Härting K, Späthe K, Rutke S, Konik E, Fridman R, Berger U, Schmitt M, Kuhn W, Lengyel E. Schmalfeldt B, et al. Among authors: lengyel e. Clin Cancer Res. 2001 Aug;7(8):2396-404. Clin Cancer Res. 2001. PMID: 11489818

3

Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.

Lengyel E, Schmalfeldt B, Konik E, Späthe K, Härting K, Fenn A, Berger U, Fridman R, Schmitt M, Prechtel D, Kuhn W. Lengyel E, et al. Gynecol Oncol. 2001 Aug;82(2):291-8. doi: 10.1006/gyno.2001.6243. Gynecol Oncol. 2001. PMID: 11531282

4

C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu.

Lengyel E, Prechtel D, Resau JH, Gauger K, Welk A, Lindemann K, Salanti G, Richter T, Knudsen B, Vande Woude GF, Harbeck N. Lengyel E, et al. Int J Cancer. 2005 Feb 10;113(4):678-82. doi: 10.1002/ijc.20598. Int J Cancer. 2005. PMID: 15455388

5

c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.

Sawada K, Radjabi AR, Shinomiya N, Kistner E, Kenny H, Becker AR, Turkyilmaz MA, Salgia R, Yamada SD, Vande Woude GF, Tretiakova MS, Lengyel E. Sawada K, et al. Among authors: lengyel e. Cancer Res. 2007 Feb 15;67(4):1670-9. doi: 10.1158/0008-5472.CAN-06-1147. Cancer Res. 2007. PMID: 17308108

6

Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum.

Kenny HA, Krausz T, Yamada SD, Lengyel E. Kenny HA, et al. Among authors: lengyel e. Int J Cancer. 2007 Oct 1;121(7):1463-72. doi: 10.1002/ijc.22874. Int J Cancer. 2007. PMID: 17546601

7

The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.

Kenny HA, Kaur S, Coussens LM, Lengyel E. Kenny HA, et al. Among authors: lengyel e. J Clin Invest. 2008 Apr;118(4):1367-79. doi: 10.1172/JCI33775. J Clin Invest. 2008. PMID: 18340378 Free PMC article.

8

Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.

Sawada K, Mitra AK, Radjabi AR, Bhaskar V, Kistner EO, Tretiakova M, Jagadeeswaran S, Montag A, Becker A, Kenny HA, Peter ME, Ramakrishnan V, Yamada SD, Lengyel E. Sawada K, et al. Among authors: lengyel e. Cancer Res. 2008 Apr 1;68(7):2329-39. doi: 10.1158/0008-5472.CAN-07-5167. Cancer Res. 2008. PMID: 18381440 Free PMC article.

9

Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer.

Terplan M, Temkin S, Tergas A, Lengyel E. Terplan M, et al. Among authors: lengyel e. Gynecol Oncol. 2008 Nov;111(2):173-8. doi: 10.1016/j.ygyno.2008.08.013. Epub 2008 Sep 26. Gynecol Oncol. 2008. PMID: 18823649 Free PMC article.

10

MMP-2 functions as an early response protein in ovarian cancer metastasis.

Kenny HA, Lengyel E. Kenny HA, et al. Among authors: lengyel e. Cell Cycle. 2009 Mar 1;8(5):683-8. doi: 10.4161/cc.8.5.7703. Epub 2009 Mar 25. Cell Cycle. 2009. PMID: 19221481 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters